Join us for an insightful webinar, led by Dr. Regina Demlová exploring the vital role of personalised immunotherapy in the treatment of rare diseases. The webinar will focus on the specifics and challenges of drug development in Advanced Therapy Medicinal Products (ATMP) and personalised medicine.
In this webinar, you will learn about:
• Specifics and challenges of drug development in Advanced Therapy Medicinal Products (ATMP)
• The potential of personalized immunotherapy for rare diseases
The webinar will be hosted by SPARK Faculty of Medicine, Masaryk University.
Online via MS Teams | Please register here!
Registration to the webinar is required in advance. Please register no later than July 2nd and you will get the MS Teams link for this webinar the day before.
SPARK Europe is the joint network of SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Norway, SPARK Poland, SPARK Tel Aviv, SPARK Denmark, SPARK Zürich and SPARK at the Faculty of Medicine, Masaryk University. European SPARK programs are members of SPARK Global network. The purpose of SPARK programs is to provide the education and mentorship necessary to advance research discoveries from the bench to the bedside, hence to increase the maturity of academic and clinical discoveries towards practical solutions that address unmet needs in the life science and health tech space. The program follows the same principles that have been the cornerstones of SPARK at Stanford since it was established by Professor Daria Mochly-Rosen and Kevin Grimes in 2006 for advancing new biomedical research discoveries into promising new treatments for patients.
